{"id":"https://openalex.org/W2081702317","doi":"https://doi.org/10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","title":"The pharmacology of orally administered chemotherapy: A reappraisal","display_name":"The pharmacology of orally administered chemotherapy: A reappraisal","publication_year":1986,"publication_date":"1986-07-15","ids":{"openalex":"https://openalex.org/W2081702317","doi":"https://doi.org/10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","mag":"2081702317","pmid":"https://pubmed.ncbi.nlm.nih.gov/3459570"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","doi":"https://doi.org/10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819860715%2958%3A2%20%3C473%3A%3AAID-CNCR2820581311%3E3.0.CO%3B2-0","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819860715%2958%3A2%20%3C473%3A%3AAID-CNCR2820581311%3E3.0.CO%3B2-0","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109539569","display_name":"David G. Poplack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David G. Poplack","raw_affiliation_strings":["Pediatric Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024249524","display_name":"Frank M. Balis","orcid":"https://orcid.org/0000-0002-8117-6926","observed_orcids":["https://orcid.org/0000-0002-8117-6926"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank M. Balis","raw_affiliation_strings":["Pediatric Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042376097","display_name":"Solomon Zimm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Solomon Zimm","raw_affiliation_strings":["Pediatric Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109539569"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":3.5088,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.92539207,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"58","issue":"S2","first_page":"473","last_page":"480"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/clinical-pharmacology","display_name":"clinical pharmacology","score":0.7860000133514404},{"id":"https://openalex.org/keywords/6-mercaptopurine","display_name":"6-mercaptopurine","score":0.9789999723434448},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9480000138282776},{"id":"https://openalex.org/keywords/maintenance-chemotherapy","display_name":"maintenance chemotherapy","score":0.8859999775886536},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.871999979019165},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.703000009059906},{"id":"https://openalex.org/keywords/pediatric-oncology","display_name":"pediatric oncology","score":0.7070000171661377},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9191070199012756},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.6827635765075684},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6767367124557495},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6481886506080627},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.634738564491272},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.617135226726532},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6055099964141846},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5944638848304749},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5400609970092773},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5261801481246948},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.48066461086273193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2372858226299286}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000493","descriptor_name":"Allopurinol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002940","descriptor_name":"Circadian Rhythm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005502","descriptor_name":"Food","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007263","descriptor_name":"Infusions, Parenteral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007945","descriptor_name":"Leukemia, Lymphoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015122","descriptor_name":"Mercaptopurine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015122","descriptor_name":"Mercaptopurine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","doi":"https://doi.org/10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819860715%2958%3A2%20%3C473%3A%3AAID-CNCR2820581311%3E3.0.CO%3B2-0","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:3459570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3459570","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","doi":"https://doi.org/10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19860715)58:2+<473::aid-cncr2820581311>3.0.co;2-0","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819860715%2958%3A2%20%3C473%3A%3AAID-CNCR2820581311%3E3.0.CO%3B2-0","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2081702317.pdf","grobid_xml":"https://content.openalex.org/works/W2081702317.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W104379152","https://openalex.org/W129917815","https://openalex.org/W1507403192","https://openalex.org/W1575121669","https://openalex.org/W1909437603","https://openalex.org/W1965688215","https://openalex.org/W1970540527","https://openalex.org/W1977261945","https://openalex.org/W2014156964","https://openalex.org/W2024640823","https://openalex.org/W2030431646","https://openalex.org/W2031561085","https://openalex.org/W2044118975","https://openalex.org/W2057568639","https://openalex.org/W2072032394","https://openalex.org/W2073836981","https://openalex.org/W2087782897","https://openalex.org/W2103790960","https://openalex.org/W2226703340","https://openalex.org/W2396703508","https://openalex.org/W3043800854","https://openalex.org/W4233801785","https://openalex.org/W4234190839"],"related_works":["https://openalex.org/W3034001204","https://openalex.org/W1983922888","https://openalex.org/W7160939850","https://openalex.org/W2440786045","https://openalex.org/W2284131574","https://openalex.org/W2416649069","https://openalex.org/W4386573041","https://openalex.org/W2072032394","https://openalex.org/W1990486388","https://openalex.org/W188653012"],"abstract_inverted_index":{"Rational":[0],"treatment":[1],"of":[2,9,13,21,34,47,58,69,93,96,129,143,154,158,166,170],"pediatric":[3],"malignancies":[4],"requires":[5],"a":[6,155],"detailed":[7],"knowledge":[8],"the":[10,27,31,40,45,67,94,110,138,141,152,167],"clinical":[11,32,168],"pharmacology":[12,33,95,169],"those":[14],"antineoplastic":[15],"agents":[16,23,42],"used":[17],"therapeutically.":[18],"A":[19,162],"number":[20],"different":[22],"are":[24,44,88],"administered":[25,98],"by":[26],"oral":[28,59,76,86,134,159],"route.":[29],"Recently,":[30],"6-mercaptopurine":[35],"(6-MP)":[36],"and":[37,78,109,136,172],"methotrexate":[38],"(MTX),":[39],"two":[41],"that":[43,79,101,118,140],"mainstay":[46],"maintenance":[48,160,179],"chemotherapy":[49,180],"in":[50,145,174,183],"acute":[51],"lymphoblastic":[52],"leukemia":[53],"(ALL),":[54],"were":[55],"investigated.":[56],"Studies":[57],"6-MP":[60,81,130,173],"indicate":[61],"that,":[62],"contrary":[63],"to":[64,125],"previous":[65],"information,":[66],"bioavailability":[68],"this":[70],"drug":[71],"is":[72,103,181],"relatively":[73],"poor":[74],"after":[75,84,133],"administration,":[77,135],"plasma":[80],"concentrations":[82,128],"achieved":[83],"uniform":[85],"dosing":[87],"highly":[89],"variable.":[90],"Similarly,":[91],"study":[92,165],"orally":[97],"MTX":[99,107,132,171],"indicates":[100],"there":[102],"little":[104],"correlation":[105],"between":[106],"dose":[108],"peak":[111],"serum":[112],"level":[113],"achieved.":[114],"These":[115],"findings":[116],"suggest":[117],"some":[119,146],"patients":[120,147,175],"may":[121,150],"not":[122],"be":[123,151],"exposed":[124],"adequate":[126],"systemic":[127],"and/or":[131],"raise":[137],"possibility":[139],"development":[142],"relapse":[144],"with":[148,176],"ALL":[149,177],"result":[153],"pharmacologic":[156],"failure":[157],"therapy.":[161],"comprehensive":[163],"prospective":[164],"undergoing":[178],"currently":[182],"progress.":[184]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}